Radiation Induced Atypical Vascular Lesion in the Breast

Area of Science:

• Vascular pathology
• Oncology
• Diagnostic criteria

Background:

• Atypical vascular lesion (AVL) was recognized as a distinct diagnosis by the WHO in November 2019.
• The potential risk of angiosarcoma development has led to recommendations for extensive surgical excision of AVL, though its efficacy is debated.

Discussion:

• The study observed a 45-fold increase in AVL diagnoses post-WHO classification update.
• Treatment varied from observation to extensive surgery, with no angiosarcoma development in the follow-up period.
• A lack of standardized treatment protocols for AVL highlights the need for evidence-based guidelines.

Key Insights:

• The revised WHO classification has substantially elevated the number of diagnosed AVL cases.
• Current treatment strategies, particularly extensive surgery, lack robust evidence of prognostic benefit for AVL patients.
• The frail population diagnosed with AVL often undergoes aggressive treatment without clear advantages.

Outlook:

• Further prospective studies are essential to establish optimal treatment strategies for atypical vascular lesions.
• Developing standardized treatment guidelines will improve patient care and outcomes for this rare condition.
• Research should focus on evaluating the long-term efficacy and necessity of extensive surgical interventions for AVL.